Dr. Prokai-Tatrai is a Professor of Pharmaceutical Sciences at UNT System College of Pharmacy at Fort Worth, TX where she is an award-winning researcher and pharmacy educator. Her primary research interest has been on innovative and multidisciplinary projects focusing on medicinal chemistry-driven drug design and delivery into the central nervous system. Her projects integrate medicinal chemistry, biopharmaceutics, pharmacokinetics, metabolism, and drug distribution studies in early-phase drug discovery and the development of neuroactive/neuroprotective agents. She has extensively published in a broad field of medicinal and pharmaceutical chemistry. The best testimony of a very recent success of her lab has been published in Science Translational Medicine describing the very first brain-selective delivery of estrogens based on a unique bioprecursor Prodrug approach. She has six issued US patents and has been an editorial board member of numerous journals and an academic editor of a successful special issue on neuroprotection

Medicinal Chemistry-based drug design and delivery into the central nervous system using prodrug approaches; Neuroprotection based on estrogens, GC/LC-MS-based bioanalytical assay development, Mass spectrometry-based proteomics.